Christian J. Kastrup

Dr. Christian Kastrup is a Senior Investigator at the Versiti Blood Research Institute and a Professor at the Medical College of Wisconsin. His appointments are in the Department of Surgery, Division of Trauma and Acute Care Surgery, and the Departments of Biochemistry, Biomedical Engineering, and Pharmacology and Toxicology. Additionally, he is an Affiliate Professor at The University of British Columbia and is a Co-founder of NanoVation Therapeutics, SeraGene Therapeutics, and CoMotion Drug Delivery Systems. Christian is a biochemist specializing in biotechnology and genetic medicines. He earned his PhD in Chemistry at the University of Chicago and completed a Postdoctoral Fellowship in Bioengineering at MIT in the lab of Dr. Robert Langer. His research is centered on understanding and controlling blood coagulation and fibrinolysis proteins. He is driven by the potential to improve health outcomes of young people by addressing the impact of hemorrhage during trauma and childbirth, as well as thrombosis-related conditions such as strokes and deep vein thrombosis. In his laboratory, Christian’s team creates RNA therapeutics, lipid nanoparticles, advanced drug delivery systems, and new blood products for transfusion medicine. They work in close collaboration with a variety of stakeholders, including the Canadian Armed Forces, the US Army, blood centers, and others within and beyond the field of blood research. This research is currently funded by the NIH, US Department of Defense, Canadian Department of National Defence, American Heart Association, Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, and others. Christian has trained and supervised over a hundred scientists and clinicians in his laboratory with these shared goals.